Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK The latest bid by Sen. John Edwards (D-N.C.) to limit prescription drug ads was dealt a fatal blow when it was voted down 59 to 39 in the U.S. Senate on Thursday.
The presidential contender has made direct-to-consumer ads for prescription drugs a focal point of his political campaign. It is expected that the Senator will continue his efforts on this front despite this latest defeat.
“We’ve won this round, but the fight is not over,” said Dick O’Brien evp and director of government affairs for the American Association of Advertising Agencies.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in